BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
4.420
-0.650 (-12.82%)
Feb 21, 2025, 4:00 PM EST - Market closed

BriaCell Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Aug - Jul.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Feb '25 Jul '24 Jul '23 Jul '22 Jul '21 Jul '20 2019 - 2015
Market Capitalization
1714106101795
Upgrade
Market Cap Growth
-56.06%-87.19%4.90%29.07%1427.05%-50.55%
Upgrade
Enterprise Value
11127757595
Upgrade
Last Close Price
4.4211.29100.3597.5076.20107.93
Upgrade
PB Ratio
4.45-5.08-28.189.822.84-1.43
Upgrade
P/TBV Ratio
7.76--10.052.87-
Upgrade
Debt / Equity Ratio
----0.00-0.11
Upgrade
Quick Ratio
1.650.2111.8043.64102.880.01
Upgrade
Current Ratio
1.650.4914.9645.00103.810.07
Upgrade
Return on Equity (ROE)
-536.81%--619.75%-141.25%-114.78%-
Upgrade
Return on Assets (ROA)
-129.07%-126.11%-41.71%-18.99%-14.89%-509.24%
Upgrade
Return on Capital (ROIC)
-601.59%--444.01%-50.26%-35.58%-
Upgrade
Earnings Yield
-100.40%-35.14%-19.08%-26.45%-17.58%-78.18%
Upgrade
FCF Yield
-144.79%-180.30%-22.31%-12.30%-9.86%-24.59%
Upgrade
Buyback Yield / Dilution
-21.51%-5.35%-0.81%-242.82%-533.09%-23.16%
Upgrade
Total Shareholder Return
-21.51%-5.35%-0.81%-242.82%-533.09%-23.16%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.